NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/21/2024
Back to search
Official data from USPTO
TIBSOVO IVOSIDENIB TABLETS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
08/21/2024
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
08/04/2017
Registration date
10/16/2018
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/21/2024
Last transaction
08/21/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/20/2018
First use in commerce
07/20/2018
Drawing code
3
Owner type
16
Owner location
BOSTON, MA, US
Examiner
BECHHOFER, YOCHEVED D
Current location
Historical data usage
Mark description
The mark consists of 7 rays beneath a crescent, next to the word "TIBSOVO" in stylized lettering, above the words "IVOSIDENIB TABLETS" in stylized lettering.
Holders and representatives
Holders
SERVIER PHARMACEUTICALS, LLC
Agios Pharmaceuticals, Inc.
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-cancer preparationspharmaceutical products for the prevention and treatment of cancerbiological preparations for the treatment of cancer
Publications
History of USPTO decisions and trademark events.
31 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/21/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/21/2024
E815
TEAS SECTION 8 & 15 RECEIVED
02/05/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/16/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/09/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/28/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/28/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/28/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
10/16/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/14/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/13/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/04/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/04/2018
IUAF
USE AMENDMENT FILED
08/03/2018
EISU
TEAS STATEMENT OF USE RECEIVED
08/03/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/27/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/02/2018
PUBO
PUBLISHED FOR OPPOSITION
01/02/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/13/2017
ALIE
ASSIGNED TO LIE
11/26/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/14/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
11/13/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/13/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
11/13/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/13/2017
DOCK
ASSIGNED TO EXAMINER
11/07/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/29/2017
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/10/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/09/2017
NWAP
NEW APPLICATION ENTERED
08/08/2017
Continuous trademark protection
Get notified about every new filing that threatens TIBSOVO IVOSIDENIB TABLETS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.